Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis

被引:45
作者
Gundling, Felix [1 ]
Schmidtler, Fabian [2 ]
Hapfelmeier, Alexander [3 ]
Schulte, Benjamin [4 ]
Schmidt, Thomas [1 ]
Pehl, Christian [5 ]
Schepp, Wolfgang [1 ]
Seidl, Holger [1 ]
机构
[1] Tech Univ Munich, Dept Gastroenterol Hepatol & Gastrointestinal Onc, Bogenhausen Acad Teaching Hosp, D-81925 Munich, Germany
[2] Tech Univ Munich, Dept Cardiol, Bogenhausen Acad Teaching Hosp, D-81925 Munich, Germany
[3] Univ Munich, Tech Univ Munich, Inst Med Stat & Epidemiol, Munich, Germany
[4] Tech Univ Munich, Dept Rheumatol & Immunol, Bogenhausen Acad Teaching Hosp, D-81925 Munich, Germany
[5] Vilsbiburg Hosp, Dept Internal Med, Vilsbiburg, Germany
关键词
calprotectin; cirrhosis; hepatic encephalopathy; spontaneous bacterial peritonitis; INFLAMMATORY-BOWEL-DISEASE; CRITICAL FLICKER FREQUENCY; LIVER-DISEASE; PORTAL-HYPERTENSION; PLASMA CALPROTECTIN; OVERGROWTH; ASCITES; MARKERS; GASTROENTEROLOGY; QUANTIFICATION;
D O I
10.1111/j.1478-3231.2011.02577.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: Bacterial translocation, causing intestinal inflammation, is one of the key mechanisms in the pathogenesis of hepatic encephalopathy (HE) and spontaneous bacterial peritonitis (SBP) The presence of fecal calprotectin quantitatively relates to intestinal neutrophil migration and is therefore considered as a marker of intestinal inflammation. We aimed to assess the role of fecal calprotectin concentrations (FCCs) in diagnosing the onset and severity of HE and SBP. Methods: Sixty-one cirrhotics were prospectively included. Forty-two subjects served as controls. Several complications of cirrhosis were diagnosed by reference methods. Stool samples were collected for measuring FCCs. Patients revealing other causes of abnormal calprotectin results, e. g. gastrointestinal bleeding or inflammatory bowel disease were excluded. Multivariate analysis of cirrhosis-associated complications and their relation to FCCs was performed. Results: Fecal calprotectin concentrations were higher in cirrhotics compared with controls (P < 0.001). Among cirrhotics, FCCs were elevated dependent on the severity of liver disease as assessed by Child-and model for end-stage liver disease-scores. The corresponding correlation co-efficients by Spearman's were 0.577 (P < 0.001) and 0.303 (P = 0.018) respectively. A correlation emerged between elevated FCCs and HE grading as measured by West-Haven criteria and critical flicker frequency (both P < 0.001; sensitivity = 0.94 and 0.93, specificity = 0.95 and 0.89 respectively) and SBP (P < 0.02; sensitivity = 0.71, specificity = 0.79). FCCs were higher in cirrhotic subjects with additional extra-intestinal inflammation (P < 0.01; sensitivity = 0.65, specificity = 0.8). The Pearsons correlation coefficients were 0.190 and 0.164 revealing no influence (P = 0.142 and P = 0.207) of laboratory parameters of systemic inflammation on FCCs in cirrhotic subgroup. Conclusions: Fecal calprotectin concentrations serve as a screening tool for HE and SBP. Assessment of FCCs may faciliate grading of HE-severity.
引用
收藏
页码:1406 / 1415
页数:10
相关论文
共 35 条
[1]  
Arora Sanjay, 2006, CJEM, V8, P433
[2]   Organ allocation for chronic liver disease: model for end-stage liver disease and beyond [J].
Asrani, Sumeet K. ;
Kim, W. Ray .
CURRENT OPINION IN GASTROENTEROLOGY, 2010, 26 (03) :209-213
[3]  
Bauer TM, 2002, AM J GASTROENTEROL, V97, P2364
[4]   Can calprotectin predict relapse risk in inflammatory bowel disease? [J].
D'Inca, Renata ;
Dal Pont, Elisabetta ;
Di Leo, Vincenza ;
Benazzato, Luca ;
Martinato, Matteo ;
Lamboglia, Francesca ;
Oliva, Lydia ;
Sturniolo, Giacomo Carlo .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (08) :2007-2014
[5]   Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998 [J].
Ferenci, P ;
Lockwood, A ;
Mullen, K ;
Tarter, R ;
Weissenborn, K ;
Blei, AT .
HEPATOLOGY, 2002, 35 (03) :716-721
[6]   Gut microflora in the pathogenesis of the complications of cirrhosis [J].
Garcia-Tsao, G .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (02) :353-372
[7]   Current management of the complications of cirrhosis and portal hypertension: Variceal hemorrhage, ascites, and spontaneous bacterial peritonitis [J].
Garcia-Tsao, G .
GASTROENTEROLOGY, 2001, 120 (03) :726-748
[8]   Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease [J].
Gisbert, J. P. ;
McNicholl, A. G. .
DIGESTIVE AND LIVER DISEASE, 2009, 41 (01) :56-66
[9]   Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension [J].
Gunnarsdottir, SA ;
Sadik, R ;
Shev, S ;
Simrén, M ;
Sjövall, H ;
Stotzer, PO ;
Abrahamsson, H ;
Olsson, R ;
Björnsson, ES .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (06) :1362-1370
[10]   Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy [J].
Gupta, Ankur ;
Dhiman, Radha K. ;
Kumari, Savita ;
Rana, Satyavati ;
Agarwal, Ritesh ;
Duseja, Ajay ;
Chawla, Yogesh .
JOURNAL OF HEPATOLOGY, 2010, 53 (05) :849-855